Yutao Liu Selected Research

rutaevin

12/2020

Cytochrome P450 Mediated Bioactivation of Rutaevin, a Bioactive and Potentially Hepatotoxic Component of Evodia Rutaecarpa.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yutao Liu Research Topics

Disease

23	Neoplasms (Cancer) 07/2022 - 01/2010
21	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2022 - 03/2011
15	Glaucoma 01/2022 - 01/2008
15	Open-Angle Glaucoma (Glaucoma, Open Angle) 11/2019 - 04/2010
9	Adenocarcinoma of Lung 01/2021 - 05/2014
7	Neoplasm Metastasis (Metastasis) 12/2021 - 08/2013
6	Lymphoma (Lymphomas) 07/2022 - 05/2015
6	Lung Neoplasms (Lung Cancer) 02/2022 - 10/2017
5	Wounds and Injuries (Trauma) 01/2022 - 05/2015
5	Infections 12/2021 - 01/2019
5	Keratoconus 12/2020 - 06/2012
5	Exfoliation Syndrome 01/2018 - 04/2010
5	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2017 - 06/2013
4	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 07/2022 - 10/2017
4	Brain Neoplasms (Brain Tumor) 12/2021 - 03/2012
4	Disease Progression 01/2021 - 03/2011
4	Inflammation (Inflammations) 01/2021 - 02/2018
3	Parkinson Disease (Parkinson's Disease) 01/2021 - 12/2017
3	Osteoarthritis 12/2020 - 01/2017
3	Inborn Genetic Diseases (Disease, Hereditary) 12/2017 - 01/2015
2	Stomach Neoplasms (Stomach Cancer) 07/2022 - 01/2019
2	Ataxia (Dyssynergia) 01/2021 - 06/2011
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 01/2021
2	Bone Diseases (Bone Disease) 01/2021 - 08/2020
2	Machado-Joseph Disease (Spinocerebellar Ataxia Type 3) 01/2021 - 12/2019
2	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2016
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2020 - 10/2017
2	Parkinsonian Disorders (Parkinsonism) 10/2018 - 12/2017
2	Hypoxia (Hypoxemia) 02/2018 - 10/2017
2	Adenocarcinoma 01/2017 - 08/2013
1	Sarcoma (Soft Tissue Sarcoma) 02/2022
1	Aniridia 01/2022
1	Atrophic Muscular Disorders 01/2022
1	Muscular Atrophy (Muscle Atrophy) 01/2022
1	Atrophy 01/2022
1	Hyperglycemia 11/2021
1	Diabetes Mellitus 11/2021
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2021
1	Cognitive Dysfunction 01/2021
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 12/2020

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2015
12	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2015
11	Biomarkers (Surrogate Marker)IBA 07/2022 - 11/2016
8	Tyrosine Kinase InhibitorsIBA 01/2021 - 08/2013
7	ErbB Receptors (EGF Receptor)IBA 01/2021 - 08/2013
7	Pharmaceutical PreparationsIBA 01/2020 - 12/2010
6	Gefitinib (Iressa)FDA Link 01/2018 - 09/2011
5	PlatinumIBA 10/2019 - 03/2011
4	EnzymesIBA 07/2022 - 02/2018
4	osimertinibIBA 12/2020 - 01/2018
4	Docetaxel (Taxotere)FDA Link 03/2012 - 12/2010
4	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2012 - 01/2008
3	LigandsIBA 07/2022 - 12/2010
3	DNA (Deoxyribonucleic Acid)IBA 10/2019 - 06/2011
3	trabecular meshwork-induced glucocorticoid response proteinIBA 01/2012 - 04/2011
2	Immunoglobulin G (IgG)IBA 07/2022 - 01/2020
2	Circulating Tumor DNAIBA 07/2022 - 12/2020
2	AutoantibodiesIBA 07/2022 - 01/2020
2	Sorafenib (BAY 43-9006)FDA Link 02/2022 - 03/2011
2	CollagenIBA 11/2021 - 01/2021
2	RNA (Ribonucleic Acid)IBA 12/2020 - 01/2020
2	Glucose (Dextrose)FDA LinkGeneric 10/2020 - 08/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 03/2016
2	betaglycan (TGFBR3)IBA 01/2020 - 07/2015
2	Pemetrexed (MTA)FDA Link 10/2019 - 01/2017
2	Adenosine Triphosphate (ATP)IBA 04/2019 - 10/2017
2	CrizotinibIBA 04/2019 - 01/2019
2	Gemcitabine FDA Link 01/2017 - 03/2011
2	Biological ProductsIBA 03/2016 - 10/2014
2	MicellesIBA 03/2012 - 06/2011
2	tocophersolanIBA 03/2012 - 06/2011
2	Folic Acid (Vitamin M)FDA LinkGeneric 07/2011 - 01/2010
1	AntibodiesIBA 07/2022
1	dabrafenibIBA 02/2022
1	trametinibIBA 02/2022
1	Valine (L-Valine)FDA Link 02/2022
1	Anaplastic Lymphoma KinaseIBA 01/2022
1	atalurenIBA 01/2022
1	O Antigens (O Antigen)IBA 12/2021
1	Type III Secretion SystemsIBA 12/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 12/2021
1	dacomitinibIBA 12/2021
1	anlotinibIBA 02/2021
1	durvalumabIBA 02/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Transforming Growth Factor-beta Type II ReceptorIBA 01/2021
1	Pentazocine (Talwin)FDA LinkGeneric 01/2021
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2021
1	Ataxin-3IBA 01/2021
1	rutaevinIBA 12/2020
1	MagnesiumIBA 11/2020

Therapy/Procedure

20	Therapeutics 07/2022 - 03/2011
13	Drug Therapy (Chemotherapy) 07/2022 - 03/2011
4	Immunotherapy 02/2021 - 03/2015
4	Adjuvant Chemotherapy 01/2019 - 12/2014
2	Radiotherapy 02/2021 - 08/2013
2	Transplantation 10/2018 - 01/2017
1	Chemoradiotherapy 02/2021
1	Activities of Daily Living (ADL) 01/2021
1	Immunomodulation 01/2021